9-133354897-G-C

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_003172.4(SURF1):​c.167C>G​(p.Ala56Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00431 in 1,613,944 control chromosomes in the GnomAD database, including 63 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 28 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 35 hom. )

Consequence

SURF1
NM_003172.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.737
Variant links:
Genes affected
SURF1 (HGNC:11474): (SURF1 cytochrome c oxidase assembly factor) This gene encodes a protein localized to the inner mitochondrial membrane and thought to be involved in the biogenesis of the cytochrome c oxidase complex. The protein is a member of the SURF1 family, which includes the related yeast protein SHY1 and rickettsial protein RP733. The gene is located in the surfeit gene cluster, a group of very tightly linked genes that do not share sequence similarity, where it shares a bidirectional promoter with SURF2 on the opposite strand. Defects in this gene are a cause of Leigh syndrome, a severe neurological disorder that is commonly associated with systemic cytochrome c oxidase deficiency. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a chain Surfeit locus protein 1 (size 299) in uniprot entity SURF1_HUMAN there are 17 pathogenic changes around while only 2 benign (89%) in NM_003172.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0028353333).
BP6
Variant 9-133354897-G-C is Benign according to our data. Variant chr9-133354897-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 139372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-133354897-G-C is described in UniProt as null. Variant chr9-133354897-G-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0123 (1871/152268) while in subpopulation AFR AF= 0.0354 (1468/41526). AF 95% confidence interval is 0.0338. There are 28 homozygotes in gnomad4. There are 892 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 28 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SURF1NM_003172.4 linkc.167C>G p.Ala56Gly missense_variant Exon 3 of 9 ENST00000371974.8 NP_003163.1 Q15526-1E5KRX5
SURF1NM_001280787.1 linkc.-161C>G 5_prime_UTR_variant Exon 2 of 8 NP_001267716.1 Q15526A0A087WYS9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SURF1ENST00000371974.8 linkc.167C>G p.Ala56Gly missense_variant Exon 3 of 9 1 NM_003172.4 ENSP00000361042.3 Q15526-1
SURF1ENST00000615505.4 linkc.-161C>G 5_prime_UTR_variant Exon 2 of 8 1 ENSP00000482067.1 A0A087WYS9
SURF1ENST00000437995.1 linkn.113C>G non_coding_transcript_exon_variant Exon 2 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.0123
AC:
1866
AN:
152150
Hom.:
29
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0353
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00837
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00316
Gnomad OTH
AF:
0.0143
GnomAD3 exomes
AF:
0.00510
AC:
1283
AN:
251400
Hom.:
19
AF XY:
0.00458
AC XY:
622
AN XY:
135880
show subpopulations
Gnomad AFR exome
AF:
0.0358
Gnomad AMR exome
AF:
0.00564
Gnomad ASJ exome
AF:
0.000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00349
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.00302
Gnomad OTH exome
AF:
0.00554
GnomAD4 exome
AF:
0.00348
AC:
5088
AN:
1461676
Hom.:
35
Cov.:
32
AF XY:
0.00341
AC XY:
2481
AN XY:
727138
show subpopulations
Gnomad4 AFR exome
AF:
0.0339
Gnomad4 AMR exome
AF:
0.00631
Gnomad4 ASJ exome
AF:
0.000957
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00368
Gnomad4 FIN exome
AF:
0.000564
Gnomad4 NFE exome
AF:
0.00251
Gnomad4 OTH exome
AF:
0.00639
GnomAD4 genome
AF:
0.0123
AC:
1871
AN:
152268
Hom.:
28
Cov.:
32
AF XY:
0.0120
AC XY:
892
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.0354
Gnomad4 AMR
AF:
0.00836
Gnomad4 ASJ
AF:
0.00230
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00228
Gnomad4 FIN
AF:
0.000565
Gnomad4 NFE
AF:
0.00316
Gnomad4 OTH
AF:
0.0142
Alfa
AF:
0.000653
Hom.:
0
Bravo
AF:
0.0141
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.0320
AC:
141
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00544
AC:
661
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.00256
EpiControl
AF:
0.00302

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Dec 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Dec 04, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 22488715, 27884173, 16091512) -

Sep 13, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SURF1: BP4, BS1, BS2 -

not specified Benign:1
Feb 18, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Leigh syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
0.90
DANN
Benign
0.74
DEOGEN2
Benign
0.29
T
Eigen
Benign
-0.97
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.35
N
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
1.8
L
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.70
N
REVEL
Benign
0.12
Sift
Benign
0.24
T
Sift4G
Benign
0.33
T
Polyphen
0.32
B
Vest4
0.20
MVP
0.68
MPC
0.031
ClinPred
0.0030
T
GERP RS
2.1
Varity_R
0.032
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116779216; hg19: chr9-136221752; API